Dr. Torra Jones, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Onetransam Drive, 360, Oakbrook Terrace, IL 60181 Phone: 630-785-9100 Fax: 630-785-9199 |
Charlie F Gude, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2 Transam Plaza Dr Ste 410, Oakbrook Terrace, IL 60181 Phone: 266-259-1631 |
Jawwad Hussain, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1s450 Summit Ave Ste 165, Oakbrook Terrace, IL 60181 Phone: 630-320-6871 Fax: 630-385-0026 |
Dr. Jibran Ahmed, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1s450 Summit Ave Ste 180a, Oakbrook Terrace, IL 60181 Phone: 630-468-0442 |
Dr. Romeo Rodriguez Memije Sr., MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1610 Astor Ave, Oakbrook Terrace, IL 60181 Phone: 630-889-9251 Fax: 630-889-9251 |
Merrill Ken Galera, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 17w300 22nd St, Suite 320, Oakbrook Terrace, IL 60181 Phone: 630-589-5010 Fax: 630-589-5011 |
Mona Clor, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2 Transam Plaza Dr Ste 410, Oakbrook Terrace, IL 60181 Phone: 866-259-1631 |
Syed Mohsin Rehman, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1s450 Summit Ave Ste 165, Oakbrook Terrace, IL 60181 Phone: 708-747-4000 Fax: 630-385-0026 |
News Archive
According to the Census Bureau's Quarterly Services Survey, total revenue at health care and social-assistance firms rose 3 percent in the second quarter of the year. But analysts described the increase as modest.
Patients with acute coronary syndromes (ACS) who are at high risk for bleeding have significantly lower rates of target lesion revascularisation and fewer adverse events after undergoing percutaneous coronary intervention (PCI) with a polymer-free biolimus-A (BA9) drug-coated stent than with those receiving a bare metal stent (BMS) in results from a sub-study of the LEADERS FREE trial reported for the first time in a late-breaker session at EuroPCR 2016.
Raptor Pharmaceutical Corp., announced it has entered into a securities purchase agreement in connection with a private placement, or PIPE financing. Upon the closing of the PIPE financing, Raptor will receive gross proceeds of approximately $15 million resulting from the sale of 4,897,614 units at a purchase price of $3.075 per unit.
Watson Pharmaceuticals, Inc., a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc., a Nevada Corporation, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its 50 mg, 100 mg, 150mg, 200 mg, and 250mg strength armodafinil tablets prior to the expiration of patents owned by Cephalon France.
› Verified 6 days ago